Aesculap acquires assets of Aragon Surgical

Aesculap announced today that it has acquired the assets of Aragon Surgical, Inc. Aragon Surgical specializes in advanced radio frequency (RF) electrosurgical instruments for tissue fusion and cutting. The Caiman® instruments are the only RF devices on the market with an articulating jaw-technology, which allows the surgeon unparalleled maneuverability at the surgical site. The Caiman advanced energy product line complements Aesculap's already extensive line of endoscopic and open surgical instruments, positioning the company to better meet the needs of the changing medical community.

"We are very excited about the inclusion of the Caiman product line into the Aesculap family of surgical instruments. The Caiman's unique articulating jaw design and proprietary Lektrafuse® technology provide improved clinical benefits. This acquisition will widen the scope of our surgical instrument portfolio and enhance Aesculap's line of products to improve patient care," said Chuck DiNardo, President of Aesculap, Inc.

"This transaction will allow for increased distribution of the Caiman product line," said Roseanne Varner, President and Chief Executive Officer of Aragon, "while providing our customers with the continued high quality service they have come to expect."